- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 16/10 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de virus de virus à ARN
Détention brevets de la classe C07K 16/10
Brevets de cette classe: 5067
Historique des publications depuis 10 ans
|
236
|
268
|
279
|
289
|
437
|
545
|
529
|
471
|
300
|
95
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
141 |
| Vanderbilt University | 2014 |
78 |
| The Scripps Research Institute | 1342 |
76 |
| The Rockefeller University | 582 |
75 |
| Humabs Biomed SA | 121 |
74 |
| Regeneron Pharmaceuticals, Inc. | 4689 |
74 |
| Duke University | 3182 |
60 |
| California Institute of Technology | 4042 |
48 |
| VIR Biotechnology, Inc. | 153 |
47 |
| The Wistar Institute of Anatomy and Biology | 481 |
46 |
| Dana-Farber Cancer Institute, Inc. | 2657 |
40 |
| Academia Sinica | 958 |
35 |
| International AIDS Vaccine Initiative | 90 |
35 |
| The Trustees of Columbia University in the City of New York | 3638 |
34 |
| The Trustees of the University of Pennsylvania | 4410 |
34 |
| Institut Pasteur | 785 |
31 |
| The Regents of the University of California | 20694 |
29 |
| Visterra, Inc. | 124 |
29 |
| Massachusetts Institute of Technology | 10237 |
28 |
| The University of North Carolina at Chapel Hill | 2092 |
27 |
| Autres propriétaires | 4026 |